Bettolini, L.; Bighetti, S.; Ferrucci, S.M.; Marzano, A.V.; Barei, F.; Narcisi, A.; Bianco, M.; Carugno, A.; Zerbinati, N.; Ribero, S.;
et al. Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study. Antibodies 2025, 14, 75.
https://doi.org/10.3390/antib14030075
AMA Style
Bettolini L, Bighetti S, Ferrucci SM, Marzano AV, Barei F, Narcisi A, Bianco M, Carugno A, Zerbinati N, Ribero S,
et al. Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study. Antibodies. 2025; 14(3):75.
https://doi.org/10.3390/antib14030075
Chicago/Turabian Style
Bettolini, Luca, Stefano Bighetti, Silvia Mariel Ferrucci, Angelo Valerio Marzano, Francesca Barei, Alessandra Narcisi, Matteo Bianco, Andrea Carugno, Nicola Zerbinati, Simone Ribero,
and et al. 2025. "Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study" Antibodies 14, no. 3: 75.
https://doi.org/10.3390/antib14030075
APA Style
Bettolini, L., Bighetti, S., Ferrucci, S. M., Marzano, A. V., Barei, F., Narcisi, A., Bianco, M., Carugno, A., Zerbinati, N., Ribero, S., Ortoncelli, M., Pezzolo, E., Napolitano, M., Maurelli, M., Girolomoni, G., Fratton, Z., Errichetti, E., Foti, C., Dal Bello, G.,
... Rossi, M.
(2025). Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study. Antibodies, 14(3), 75.
https://doi.org/10.3390/antib14030075
